Accuray Incorporated’s ARAY share price has dipped by 8.39%, which has investors questioning if this is right time to buy.

The growth was driven by robust performance across CyberKnife, TomoTherapy (Radixact) and the newly launched Helix systems. The Helix platform secured 12 new orders in emerging markets ...

Up to 160 breast cancer patients will get free treatment on state of the art Helix Tomotherapy units on daily basis. The Edhi Foundation has announced a funding of $4 million for the equipment for ...

Before the move, Accuray had already found connections in Madison. In 2011, Accuray acquired TomoTherapy, a Madison-based radiation treatment company. TomoTherapy manufactures technology for ...